Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
This article provides general scientific information regarding standard laboratory in vitro and in vivo research contexts only, and does not constitute a validated experimental protocol, medical guidance, clinical guidance, veterinary guidance, or treatment advice.
Key Research Findings CAM Assay: BPC-157 increases blood vessel formation in chorioallantoic membrane models Wound Models: Enhanced angiogenesis observed in cutaneous wound healing studies VEGF Blockade: VEGF inhibitors (bevacizumab) partially block BPC-157's healing effects, confirming VEGF involvement L-NAME Studies: NOS inhibition reduces BPC-157 efficacy, confirming NO pathway involvement Potential Applications The angiogenic mechanism suggests utility in: Chronic Wounds: Diabetic ulcers and pressure sores with impaired healing Sports Injuries: Tendon, ligament, and muscle repair Post-Surgical: Accelerating anastomotic and incisional healing Ischemic Conditions: Enhancing blood supply to poorly perfused tissues Considerations Cancer Context: Angiogenesis is a concern in malignancy
The annual production c
The bonds that give them their structure and function are fragile in ways that most pharmaceuticals arent, as a 2025 review in Protein & Peptide Letters on therapeutic peptide stability documented: heat and environmental exposure during storage and transit break down amino acid bonds, degrading the compound before it reaches the consumer
US$ 23.00
US$ 28.00
